Choreo LLC’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$485K Sell
2,872
-171
-6% -$29.2K 0.01% 954
2025
Q4
$514K Buy
3,043
+65
+2% +$10.6K 0.01% 911
2025
Q3
$430K Sell
2,978
-93
-3% -$12.7K 0.01% 1000
2025
Q2
$389K Buy
3,071
+80
+3% +$9.82K 0.01% 1033
2025
Q1
$383K Sell
2,991
-318
-10% -$43.1K 0.01% 975
2024
Q4
$437K Sell
3,309
-129
-4% -$18.1K 0.01% 977
2024
Q3
$498K Sell
3,438
-27
-0.8% -$3.91K 0.01% 909
2024
Q2
$475K Buy
3,465
+1,228
+55% +$164K 0.01% 833
2024
Q1
$307K Sell
2,237
-479
-18% -$65.4K 0.01% 524
2023
Q4
$369K Buy
2,716
+3
+0.1% +$366 0.01% 455
2023
Q3
$332K Hold
2,713
0.01% 357
2023
Q2
$344K Sell
2,713
-35
-1% -$4.55K 0.01% 358
2023
Q1
$355K Buy
+2,748
New +$360K 0.01% 360
2018
Q2
Sell
-2,724
Closed -$291K 252
2018
Q1
$291K Buy
2,724
+26
+1% +$2.88K 0.03% 216
2017
Q4
$288K Buy
2,698
+88
+3% +$9.41K 0.03% 226
2017
Q3
$290K Buy
2,610
+558
+27% +$59.6K 0.04% 222
2017
Q2
$212K Buy
+2,052
New +$202K 0.03% 251
2016
Q2
Sell
-28,668
Closed -$2.49M 218
2016
Q1
$2.49M Buy
+28,668
New +$2.56M 0.5% 36

Other funds holding IBB

Choreo LLC's IBB Position: Q1 2026 in Review

Choreo LLC reduced its iShares Biotechnology ETF (IBB) stake by 5.6% in Q1 2026, selling an estimated $29.2K and leaving 2,872 shares worth $485K. The position accounts for 0.01% of the portfolio, ranked #954.

Choreo LLC first reported a position in IBB in Q1 2016 and has held it in 18 quarters since. The position peaked at $2.49M in Q1 2016. 917 funds tracked by Wall St. Rank hold IBB as of Q1 2026.

  • Choreo LLC held 2,872 shares of iShares Biotechnology ETF worth $485K as of Q1 2026.
  • Choreo LLC sold 171 iShares Biotechnology ETF shares in Q1 2026, an estimated $29.2K.
  • iShares Biotechnology ETF made up 0.01% of Choreo LLC's portfolio in Q1 2026, its #954 holding.
  • Choreo LLC first reported a position in iShares Biotechnology ETF in Q1 2016 and has held it in 18 quarters since.
  • Choreo LLC's iShares Biotechnology ETF position peaked at $2.49M in Q1 2016.
  • 917 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.

Based on Choreo LLC's 13F filing for Q1 2026, filed 13 May 2026.